UK Biobank selects Trineanís DropSense96TM for DNA quantitation throughout its Genotyping project

Gentbrugge, Belgium: 13 January 2014 - Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that its DropSense96TM droplet reader has been chosen by UK Biobank for automated quantification of 500,000 purified DNA samples in its Genotyping project. 

UK Biobank's Genotyping project is one of the largest genetic studies, designed to better understand the complex interaction of lifestyle and genes in disease and personalized medicine. In collaboration with Affymetrix, genetic variations in 500,000 participants are being measured using a custom-designed AxiomTM genotyping array. 

More info on the press release or on Trinean's website.


Next > Freeslate integrates the DropSense96TM for Biologics Quantification on its Biologics Formulation System

Previous > Avantium sells its crystallization systems business to Technobis